Favorable long-term follow-up results over six years for response, survival and safety with imatinib mesylate therapy in chronic phase chronic myeloid leukemia post failure of interferon-alpha treatment

Nom du journal : Blood

Année : 2008

Volume : 111

Page de départ : 1039

Page de fin : 1043

Auteurs: Hochhaus A, Druker B, Sawyers C, Guilhot F, Schiffer CA, Cortes J, Niederwieser DW, Gambacorti C, Stone RM, Goldman J, Fischer T, O'Brien SG, Reiffers J, Mone M, Krahnke T, Talpaz M, Kantarjian HM, Kantarjian HM,